Skip to main content

PHL · NZX

Promisia Healthcare (PHL)

Healthcare / Aged careCovered: FY22 - HY276 published briefings

Promisia Healthcare is an NZX-listed healthcare / aged care company. Its latest covered result is HY27, with FY22 - HY27 of source-backed result history on Annolyse.

Latest result

Latest metrics

HY27, released 11 November 2026

← Swipe to view more
PHL latest metrics
MetricValueChange
Revenue$21.8m↑ +68.7%
EBITDAF$3.8m↑ +139.4%
NPAT$1.3m—
Operating cash flow$2.3m↑ +12.7%
OCF / EBITDAF %61.0%↓ -68.6pp
Net debt$41.6m↑ +38.5%
Net debt / EBITDAF10.87x↓ -42.2%
ROE %2.3%—
DPS0.7c—
Payout ratio vs NPAT %28.9%—

Source: latest published briefing (HY27, released 11 November 2026). Change compares against the prior equivalent period: HY24, released 28 November 2023.

Valuation

Valuation

Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$33.6m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not available for this company right now.

EPS

Not available

i

Not available for this company right now.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not available for this company right now.

P/B

0.59x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

P/E over time

Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.

Loading chart...

Ask about PHL

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Financial history

Performance over time

The latest period is shown first.

← Swipe to view more
PHL metric history
MetricHY276 MONTHS11 November 2026FY2612 MONTHS28 May 2026FY2412 MONTHS29 May 2024HY246 MONTHS28 November 2023FY2312 MONTHS30 May 2023FY2212 MONTHS30 June 2022Trend
Revenue$21.8m$40.1m$29.9m$12.9m$23.8m$19m
Chart
Revenue growth %13.7%29.1%25.6%10.7%25.5%213.6%
Chart
EBITDAF$3.8m$6.6m—$1.6m$3.6m$4.5m
Chart
EBITDAF margin %17.6%16.5%—12.4%15.0%23.5%
Chart
PBT$2m$13.9m$3.6m-$0.1m$0.5m$1.9m
Chart
PBT growth %741.7%107.5%620.0%—-73.7%—
Chart
NPAT$1.3m$12.9m$1.6m—$0.7m$2m
Chart
NPAT growth %—89.7%128.6%—-65.0%n/m
Chart
Operating cash flow$2.3m$6.4m$7.5m$2.1m$7.1m$4.8m
Chart
OCF / EBITDAF %61.0%96.2%—129.6%197.5%107.1%
Chart
FCF pre-lease$1.5m$5.8m——-$6.8m$4.3m
Chart
DPS0.7c0.0c————
Chart
Payout ratio vs NPAT %28.9%n/m————
Chart
Annual payout ratio vs EPS %—n/mn/m———
Chart
ROE %2.3%23.4%6.6%—3.4%10.9%
Chart
Net debt$41.6m$38.5m$29m$30.1m$28.8m$14.7m
Chart
Net debt / EBITDAF10.87x5.82x—18.79x8.04x3.3x
Chart
Debtor days———322220
Chart
Total assets$202.8m$199.5m$84.3m$73.6m$71.8m$51.5m
Chart

Reference: annolyse.ai/companies/phl

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

More financial metrics

Additional filing-backed metrics for this company. Each point links to the relevant published briefing.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

ROE

Return on equity.

Loading chart...

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...

The setup & the reality

FY26 → HY27 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY26 said to watch

Previous analysisFY26Result releasedAnnolyse analysis published

From FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read

No quantitative forward targets are disclosed. The release describes Cromwell as now embedded and Nelson Street as effectively full, and the HY26 release referenced early-stage acquisition negotiations. The result supports the operational repositioning narrative at the EBITDAF level, but with H2 carrying virtually all reported earnings and a basis change from the acquisition and disposal, the forward run-rate cannot be cleanly inferred from the headline. Investors should weight EBITDAF rather than NPAT when projecting forward, and watch HY27 for confirmation that the H2 EBITDAF pace (roughly $4.1m on the implied split) reflects an underlying base rather than seasonal occupancy strength.

Open questions

Open questions from FY26

  • What specifically drove the H2 NPAT swing from near-breakeven in H1 to roughly $13.0m in H2, and how much was non-cash revaluation versus operating performance?
  • Why was a dividend policy set without an accompanying FY26 dividend, and what free-cash-flow threshold must be met before a first payment?
  • How does management define the steady-state EBITDAF base now that Cromwell is fully embedded and Eileen Mary fully removed?
  • What use of debt headroom is contemplated given net debt/EBITDAF at 5.8x and the acquisition negotiations flagged at HY26?
  • Will Promisia disclose a like-for-like Cromwell contribution to allow investors to isolate organic revenue and EBITDAF growth?

This briefing cannot assess the specific composition of the $7.3m gap between EBITDAF and PBT because the source material does not separately disclose revaluation, fair-value, or other non-operating items.

Latest result sources

Primary issuer documents used for the HY27 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.

Current period

PHL HY27 Interim Report

HY27 / financial report

PHL HY27 NZX Results Announcement

HY27 / results announcement

PHL HY27 Results Announcement

HY27 / results release

Prior comparable period

PHL HY26 Preliminary Financial Statements

HY26 / financial report

PHL HY26 Results Announcement

HY26 / results release

PHL HY26 NZX Results Announcement

HY26 / results announcement

Full-year context

PHL 2026 Annual Report

FY26 / financial report

Release context

FY26 Earnings Guidance Upgrade

FY26 / commentary

Presentation - ASM 2025

HY26 / commentary

Presentation - ASM 2026

HY27 / commentary

Peer context

Aged care comparison set

These companies share the same curated sub-sector label. Their reporting definitions can still differ, so compare the underlying measures before ranking them.

Archive

Briefing archive

The full chronological archive contains every published result briefing.

HY27 · Released 11 November 2026

Chatswood Retirement Limited acquisition puts Promisia Healthcare's debt headroom in focus

The NZ$25m acquisition price is relevant to debt headroom, while borrowings and gearing remain the direct evidence.

Read briefing

FY26 · Released 28 May 2026

FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read

Full-year Cromwell consolidation and a sharp H2 earnings swing lift reported NPAT while net debt/EBITDAF falls to 5.8x.

Read briefing

FY24 · Released 29 May 2024

PBT surged on a 25.6% revenue lift driven by prior-year acquisition

Revenue growth of 25.6% flatters the comparison because FY23 included a major acquisition, while a negative effective tax rate of -54.6% inflates

Read briefing

HY24 · Released 28 November 2023

Revenue up 10.7% but PBT swung to a NZ$0.1m loss as costs outpaced growth

Promisia's aged-care operations grew the top line solidly, but earnings turned negative as cost growth absorbed the revenue gain, leaving a NPAT loss

Read briefing

FY23 · Released 30 May 2023

PBT fell 73.7% as revenue growth failed to offset cost expansion

A 25.5% revenue uplift was more than consumed by higher operating costs, lifting net debt to EBITDA to 8.0x and compressing PBT to NZ$0.5m.

Read briefing

FY22 · Released 30 June 2022

First full year of acquired aged-care lifts revenue to $19.0m

Headline +213.6% growth reflects the December 2020 acquisition lapping into a full period, not underlying expansion of the existing footprint.

Read briefing
Open all 6 result briefings

Get notified when PHL publishes

Get the next Promisia Healthcare result briefing and five-year history updates by email.